Evidence map›Paper›PMID 20581130›Full record

ArticleRNA (New York, N.Y.)2010

In vitro incorporation of nonnatural amino acids into protein using tRNA(Cys)-derived opal, ochre, and amber suppressor tRNAs.

Jacob Gubbens, Soo Jung Kim, Zhongying Yang, Arthur E Johnson, William R Skach

Open access · bronzeAbstract read
In one paragraph

Article in RNA (New York, N.Y.), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Efficient Amber SuppressionACS synthetic biology · 2022
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jacob GubbensDepartment of Biochemistry and Molecular Biology, Oregon Health and Sciences University, Portland, OR 97231, USA.
Soo Jung Kim
Zhongying Yang
Arthur E Johnson
William R Skach
Oregon Health & Science University · USTexas A&M Health Science Center · US

Funding

THE INTERACTION OF AA-TRNA WITH EF-TU AND RIBOSOMESR01GM026494 · NIGMS · UNIVERSITY OF OKLAHOMA NORMAN · PI JOHNSON, ARTHUR E · 1985 to 2011
$3.7M
MECHANISMS OF POLYTOPIC PROTEIN BIOGENESIS IN THE ERR01GM053457 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI SKACH, WILLIAM R · 1996 to 2013
$3.5M
BIOGENESIS AND MOLECULAR PATHOGENESIS OF CFTRR01DK051818 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI SKACH, WILLIAM R · 1997 to 2012
$2.9M
NIDDK NIH HHS DK51818NIDDK NIH HHS R01 DK051818NIGMS NIH HHS GM53457NIGMS NIH HHS R01 GM026494NIGMS NIH HHS R01 GM053457
6 · The paper itself

Abstract

Amber suppressor tRNAs are widely used to incorporate nonnatural amino acids into proteins to serve as probes of structure, environment, and function. The utility of this approach would be greatly enhanced if multiple probes could be simultaneously incorporated at different locations in the same protein without other modifications. Toward this end, we have developed amber, opal, and ochre suppressor tRNAs derived from Escherichia coli, and yeast tRNA(Cys) that incorporate a chemically modified cysteine residue with high selectivity at the cognate UAG, UGA, and UAA stop codons in an in vitro translation system. These synthetic tRNAs were aminoacylated in vitro, and the labile aminoacyl bond was stabilized by covalently attaching a fluorescent dye to the cysteine sulfhydryl group. Readthrough efficiency (amber > opal > ochre) was substantially improved by eRF1/eRF3 inhibition with an RNA aptamer, thus overcoming an intrinsic hierarchy in stop codon selection that limits UGA and UAA termination suppression in higher eukaryotic translation systems. This approach now allows concurrent incorporation of two different modified amino acids at amber and opal codons with a combined apparent readthrough efficiency of up to 25% when compared with the parent protein lacking a stop codon. As such, it significantly expands the possibilities for incorporating nonnative amino acids for protein structure/function studies.

Indexed as

RNA, TransferAmberAmino AcidsAminoacylationAntineoplastic Combined Chemotherapy ProtocolsAsparaginaseBase PairingCodon, TerminatorCysteineDoxorubicinEscherichia coliEukaryotaPrednisoneProteinsVincristineAmberAmino AcidsAsparaginaseCodon, TerminatorCysteineDoxorubicinPrednisoneProteinsRNA, TransferVincristine

Identifiers

PMID20581130
PMCPMC2905763
OpenAlexW2135795058

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.